1Ota T,Yoshida M,Kimura M,et al.Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger[J].Int J Gynecol Cancer,2005,15 (4):657-662.
2Seli E,Tangir J.Fertility preservation options for female patients with malignancies[J].Curr Opin Obstet Gynecol,2005,17:299-308.
3Ramirez PT,Frumovitz M,Bodurka DC,et al.Hormonal therapy for the management of grade Ⅰ endometrial adenocarcinoma:a literature review[J].Gynecol Oncol,2004,95 (1):133-138.
4ACOG practice bulletin,clinical management guidelines for obstetrician-gynecologists,number 65,August 2005:management of endometrial cancer[J].Obstet Gynecol,2005,106 (2):413-425.
5Mueck AO,Seeger H.Hormone therapy after endometrial cancer[J].Horm Res,2004,62(1):40-48.
6Walter H, Gotlieb MD, Mario E. Outcome of fertility-sparing treat-ment with progeslins in young patients with endometrial cancer[ J].Obstetrit’ s & Gynecology ,2003 ,102(8) :718 - 725.
7Popli K,Sinshal G, Batta N, et al. Endnmelrial carcinoma presen-ring as infertility in a young woman [ J ]. J Ohstet Gynecol India,2005,55(4) :367 -368.
9Walter H,Gotlieb MD,Mario E. Outcome of Fertility Sparing Treatment With Progeslins in Young Patients With Endometrial Cancer[J].Obstetrit's＆Gynecology,2003,(08):718-725.
10Saaaon I E,Taylor H S. Stem cells and the Pathogensis of endometriosis[J].Ann NY Acad Sei,2008,(106).
